top of page

PEER-REVIEWED PUBLICATIONS 
(*First Author, †corresponding author)
98 publications on PubMed; 29 as first author, 13 as corresponding author.
136 publications on Google Scholar.
Total impact factor (IF): 376.273 (Journal of Citation Reports).
Research gate RG score: 36.95 (Within top 5% of all ResearchGate members)
Google Scholar Citations: 1663 (1463 since 2016), h index 20, i10 index 41 (38 since 2016)
 

  1. Fujinami K*†, Oishi A*; Japan Eye Genetics Consortium. Clinical and genetic characteristics of ten Japanese patients with PROM1-associated retinal disorder: a report of the phenotype spectrum and a literature review in the Japanese population. Am J Med Genet C Semin Med Genet. 2020. In press. IF 7.101

  2. Fujinami K*†, Liu X*; Japan Eye Genetics Consortium. RP2-associated retinal disorder in a Japanese cohort: report of novel variants and a literature review, identifying a genotype-phenotype association. Am J Med Genet C Semin Med Genet. 2020. In press. IF 7.101

  3. Yamada Y*†, Fujinami K*†, Eguchi T, Takefuji H, Mori N. Multisystem Inflammatory Syndrome in Adults after Mild SARS-CoV-2 Infection, Japan. Emerg Infect Dis. 2021 Jun;27(6):1740-1742. IF 6.259.

  4. Fujinami-Yokokawa Y, Ninomiya H, Liu X, Yang L, Pontikos N, Yoshitake K, Iwata T, Sato Y, Hashimoto T, Tsunoda K, Miyata H, Fujinami K†; Japan Eye Genetics Study (JEGC) Group. Prediction of causative genes in inherited retinal disorder from fundus photography and autofluorescence imaging using deep learning techniques. Br J Ophthalmol. 2021 In press. IF 3.611

  5. Liu X,..,Fujinami K†, Shiying Li†; for the East Asia Inherited Retinal Disease Society study group. Clinical and genetic characteristics of Stargardt disease in a large Western China cohort: report 1. Am J Med Genet C Semin Med Genet. 2020. In press. IF 7.101

  6. Georgiou M†,.., Fujinami K,.., Michaelides M. Sector Retinitis Pigmentosa: Extending the Molecular Genetics Basis and Elucidating the Natural History. Am J Ophthalmol. In press. IF 4.013

  7. Georgiou M, Fujinami K, …, Michaelides M. KCNV2-associated Retinopathy: Detailed Retinal Phenotype and Structural Endpoints - KCNV2 Study Group Report 2. Am J Ophthalmol. In press. IF 4.013.

  8. Georgiou M, Fujinami K, Michaelides M. Inherited retinal diseases: Therapeutics, clinical trials and end points-A review. Clin Exp Ophthalmol. 2021 Apr;49(3):270-288. IF 2.832

  9. Schönbach EM, …, Fujinami K, …,Scholl HPN; ProgStar Study Group. The Progression of Stargardt Disease using Volumetric Hill of Vision Analyses Over 24 Months: ProgStar Report No.15. Am J Ophthalmol. In press. IF 4.013

  10. Ozawa H, …, Fujinami K, ..,Yokogawa N. Ocular findings in Japanese patients with hydroxychloroquine retinopathy developing within 3 years of treatment. Jpn J Ophthalmol. 2021 In press. IF 1.725

  11. Murakami Y, …, Fujinami K, …, Sonoda KH. Genotype and Long-term Clinical Course of Bietti Crystalline Dystrophy in Korean and Japanese Patients. Ophthalmol Retina. 2021 Feb 23;S2468-6530(21)00063-4.

  12. Hirakata T, Fujinami K, Saito W, et al. Acute Unilateral Inner Retinal Dysfunction with Photophobia -Importance of Electrodiagnosis-. Jp J Ophthalmol. In press. IF 1.725

  13. Yang L*, Joo K*,…, Woo SJ4†, Sui R†, Fujinami K*†; for the East Asia Inherited Retinal Disease Society study group. Spatial Functional Characteristics of East Asian Patients with Occult Macular Dystrophy (Miyake disease); EAOMD Report No.2. Am J Ophthalmol. In press. IF 4.013

  14. Fujinami-Yokokawa Y*, Fujinami K*†, et al. Clinical and Genetic Characteristics of 18 Patients From 13 Japanese Families With CRX-associated Retinal Disorder: Identification of Genotype-phenotype Association. Sci Rep. 2020 Jun 12;10(1):9531. doi: 10.1038/s41598-020-65737-z. IF 3.998

  15. Li H, Wang G, Liu X, …, Fujinami K†,, Li S. Long-term follow-up of a Chinese patient with KCNV2-retinopath. Ophthalmic Genet. 2020. In press.

  16. Georgiou M, Robson AG, Fujinami K, et al. KCNV2-associated Retinopathy: Genetics, Electrophysiology and Clinical Course – KCNV2 Study Group Report 1. Am J Ophthalmol. 2020. In press.

  17. Hirose A, Katagiri S, Hayashi T,… , Fujinami K, et al. Progress of Macular Atrophy During 30 Months' Follow-Up in a Patient With Spinocerebellar Ataxia type1 (SCA1). Doc Ophthalmol. In press.

  18. Mizobuchi K, Hayashi T, Yoshitake K, Fujinami K, et al. Novel Homozygous CLN3 Missense Variant in Isolated Retinal Dystrophy: A Case Report and Electron Microscopic Findings. Mol Genet Genomic Med. In press.

  19. Liu X, Gao L, Wang G, …, Fujinami K, Meng X, Li S. Oguchi Disease Caused by a Homozygous Novel SAG Splicing Alteration Associated With the Multiple Evanescent White Dot Syndrome: A 15-month Follow-Up. Doc Ophthalmol. In press.

  20. Khan, M., Cornelis, S. S., del Pozo-Valero, M,…, Fujinami K, et al. Resolving the dark matter of ABCA4 for 1,054 Stargardt disease probands through integrated genomics and transcriptomics. Genet. Med. In press.

  21. Katagiri S, Hayashi T, Nakamura M,…, Fujinami K, et al. RDH5-related fundus albipunctatus in a large Japanese cohort. Invest Ophthalmol Vis Sci. In press.

  22. Berry V, Georgiou1 M, Fujinami K et al. Inherited Cataracts: Molecular Genetics, Clinical Features, Disease Mechanisms, and Novel Therapeutic Approaches. Br J Ophthalmol in press

  23. Liu X*, Fujinami K*†,…, Fujinami-Yokokawa Y et al. Clinical and genetic characteristics of 15 affected patients from 12 Japanese families with GUCY2D-associated retinal disorder. Transl Vis Sci Technol. In press.

  24. Murphy C,…, Fujinami K, Fujinami-Yokokawa Y et al. Phenogenon: Gene to Phenotype Associations for Rare Genetic Diseases. PLoS One. In press

  25. Yang L*, Fujinami K*†,…, Fujinami-Yokokawa Y et al. Genetic Spectrum of EYS-associated Retinal Disease in a Large Japanese Cohort: Identification of Disease-associated Variants with Relatively High Allele Frequency. Sci Rep. In press

  26. Kuniyoshi K, Hayashi T, Kameya S,…, Fujinami K, et al. Clinical Course and Electron Microscopic Findings in Lymphocytes of Patients with DRAM2-Associated Retinopathy. Int J Mol Sci. 2020 Feb 16;21(4). pii: E1331. doi: 10.3390/ijms21041331.

  27. Bouzia Z, Georgiou M, Hull S,…, Fujinami K, et al. GUCY2D-Associated Leber Congenital Amaurosis: A Retrospective Natural History Study in Preparation for Trials of Novel Therapies. Am J Ophthalmol. 2020 Feb;210:59-70. doi: 10.1016/j.ajo.2019.10.019. Epub 2019 Nov 5.

  28. Nakanishi A, Ueno S, Hayashi T,…, Fujinami K, et al. CHANGES OF CONE PHOTORECEPTOR MOSAIC IN AUTOSOMAL RECESSIVE BESTROPHINOPATHY. Retina. 2020 Jan;40(1):181-186. doi: 10.1097/IAE.0000000000002363.

  29. Georgiou M, Kane T, Tanna P,…, Fujinami K, et al. Prospective Cohort Study of Childhood-Onset Stargardt Disease: Fundus Autofluorescence Imaging, Progression, Comparison with Adult-Onset Disease, and Disease Symmetry. Am J Ophthalmol. 2019 Dec 6. pii: S0002-9394(19)30547-1. doi: 10.1016/j.ajo.2019.11.008. [Epub ahead of print]

  30. Mizobuchi K, Hayashi T, Katagiri S,…, Fujinami K, et al. Characterization of GUCA1A-associated dominant cone/cone-rod dystrophy: low prevalence among Japanese patients with inherited retinal dystrophies. Sci Rep. 2019 Nov 14;9(1):16851. doi: 10.1038/s41598-019-52660-1.

  31. Nakamura N, Tsunoda K, Mizuno Y,…, Fujinami K, et al. Clinical Stages of Occult Macular Dystrophy Based on Optical Coherence Tomographic Findings. Invest Ophthalmol Vis Sci. 2019 Nov 1;60(14):4691-4700. doi: 10.1167/iovs.19-27486.

  32. Maeda-Katahira A, Nakamura N, Hayashi T,…, Fujinami K, et al. Autosomal dominant optic atrophy with OPA1 gene mutations accompanied by auditory neuropathy and other systemic complications in a Japanese cohort. Mol Vis. 2019 Oct 5;25:559-573. eCollection 2019.

  33. Mawatari G, Fujinami K. Liu X, et al. Clinical and genetic characteristics of 14 patients from 13 Japanese families with RPGR-associated retinal disorder: report of eight novel variants. Hum Genome Var. 2019 Aug 2;6:34. doi: 10.1038/s41439-019-0065-7. eCollection 2019. Erratum in: Hum Genome Var. 2020 Feb 10;7:3.

  34. Kameya S*, Fujinami K,*, Ueno S et al. Phenotypical Characteristics of POC1B-Associated Retinopathy in Japanese Cohort: Cone Dystrophy With Normal Funduscopic Appearance. Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3432-3446. doi: 10.1167/iovs.19-26650.

  35. Strauss RW, Kong X, Ho A,…, Fujinami K, et al. Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period: ProgStar Report No. 11. JAMA Ophthalmol. 2019 Aug 1. doi: 10.1001/jamaophthalmol.2019.2885. [Epub ahead of print]

  36. Tsunoda K, Fujinami K. Yoshitake K, et al. Late-onset night blindness with peripheral flecks accompanied by progressive trickle-like macular degeneration. Doc Ophthalmol. 2019 Dec;139(3):171-184. doi: 10.1007/s10633-019-09705-7. Epub 2019 Jul 8.

  37. Fujinami-Yokokawa Y*, Pontikos N*, Yang L, ,…, Fujinami K†, et al. Prediction of Causative Genes in Inherited Retinal Disorders from Spectral-Domain Optical Coherence Tomography Utilizing Deep Learning Techniques. J Ophthalmol. 2019 Apr 9;2019:1691064. doi: 10.1155/2019/1691064. eCollection 2019.

  38. Fujinami K*†. Yang L*, Joo K* et al. Clinical and Genetic Characteristics of East Asian Patients with Occult Macular Dystrophy (Miyake Disease): East Asia Occult Macular Dystrophy Studies Report Number 1. Ophthalmology. 2019 Oct;126(10):1432-1444. doi: 10.1016/j.ophtha.2019.04.032. Epub 2019 Apr 25.

  39. Ervin AM, Strauss RW, Ahmed MI,…, Fujinami K, et al. A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned. Transl Vis Sci Technol. 2019 Apr 12;8(2):16. doi: 10.1167/tvst.8.2.16. eCollection 2019 Apr.

  40. Tanna P, Georgiou M, Strauss RW,…, Fujinami K, et al. Cross-Sectional and Longitudinal Assessment of the Ellipsoid Zone in Childhood-Onset Stargardt Disease. Transl Vis Sci Technol. 2019 Mar 1;8(2):1. doi: 10.1167/tvst.8.2.1. eCollection 2019 Mar.

  41. Suzuki K, Gocho K, Akeo K,…, Fujinami K, et al. High-Resolution Retinal Imaging Reveals Preserved Cone Photoreceptor Density and Choroidal Thickness in Female Carriers of Choroideremia. Ophthalmic Surg Lasers Imaging Retina. 2019 Feb 1;50(2):76-85. doi: 10.3928/23258160-20190129-03.

  42. Kondo H, Oku K, Katagiri S,…, Fujinami K, et al. Novel mutations in the RS1 gene in Japanese patients with X-linked congenital retinoschisis. Hum Genome Var. 2019 Jan 8;6:3. doi: 10.1038/s41439-018-0034-6. eCollection 2019.

  43. Mizobuchi K, Katagiri S, Hayashi T,…, Fujinami K, et al. Clinical findings of end-stage retinitis pigmentosa with a homozygous PDE6A variant (p.R653X). Am J Ophthalmol Case Rep. 2018 Dec 19;13:110-115. doi: 10.1016/j.ajoc.2018.12.019. eCollection 2019 Mar.

  44. Ueno S, Inooka D, Meinert M,…, Fujinami K, et al. Three cases of acute-onset bilateral photophobia. Jpn J Ophthalmol. 2019 Mar;63(2):172-180. doi: 10.1007/s10384-018-00649-0. Epub 2019 Jan 2.

  45. Fujinami K. Strauss RW, Chiang JP et al. Detailed genetic characteristics of an international large cohort of patients with Stargardt disease: ProgStar study report 8. Br J Ophthalmol. 2019 Mar;103(3):390-397. doi: 10.1136/bjophthalmol-2018-312064. Epub 2018 Jun 20.

  46. Akiyama K, Fujinami K. Watanabe K, et al. Macular dysfunction in patients with macula-on rhegmatogenous retinal detachments. Br J Ophthalmol. 2019 Mar;103(3):404-409. doi: 10.1136/bjophthalmol-2018-312153. Epub 2018 Jun 1.

  47. Ando R, Saito W, Kanda A, ,…, Fujinami K, et al. Clinical Features of Japanese Patients With Anti-ﾎｱ-enolase Antibody-Positive Autoimmune Retinopathy: Novel Subtype of Multiple Drusen. Am J Ophthalmol. 2018 Dec;196:181-196. doi: 10.1016/j.ajo.2018.08.044. Epub 2018 Sep 7.

  48. Kumaran N, Rubin GS, Kalitzeos A,…, Fujinami K, et al. A Cross-Sectional and Longitudinal Study of Retinal Sensitivity in RPE65-Associated Leber Congenital Amaurosis. Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3330-3339. doi: 10.1167/iovs.18-23873. Erratum in: Invest Ophthalmol Vis Sci. 2018 Aug;59(10):4326.

  49. Akiyama K, Fujinami K. Watanabe K, et al. VALIDITY AND EFFICACY OF INTERNAL LIMITING MEMBRANE PEELING DURING INITIAL VITRECTOMY FOR RHEGMATOGENOUS RETINAL DETACHMENT: VISUAL OUTCOMES IN MACULA-SPARING CASES. Retin Cases Brief Rep. 2018 Jun 25. doi: 10.1097/ICB.0000000000000758. [Epub ahead of print]

  50. Thompson DA, Fujinami K, Perlman I, et al. ISCEV extended protocol for the dark-adapted red flash ERG. Doc Ophthalmol. 2018 Jun;136(3):191-197. doi: 10.1007/s10633-018-9644-z. Epub 2018 Jun 22.

  51. Kong X*, Fujinami K*, Strauss RW* et al. Visual Acuity Change Over 24 Months and Its Association With Foveal Phenotype and Genotype in Individuals With Stargardt Disease: ProgStar Study Report No. 10. JAMA Ophthalmol. 2018 Aug 1;136(8):920-928. doi: 10.1001/jamaophthalmol.2018.2198.

  52. Schönbach EM, Strauss RW, Kong X,…, Fujinami K, et al. Longitudinal Changes of Fixation Location and Stability Within 12 Months in Stargardt Disease: ProgStar Report No. 12. Am J Ophthalmol. 2018 Sep;193:54-61. doi: 10.1016/j.ajo.2018.06.003. Epub 2018 Jun 8.

  53. Mahroo OA*, Fujinami K*, Moore AT et al. Retinal findings in a patient with mutations in ABCC6 and ABCA4. Eye (Lond). 2018 Sep;32(9):1542-1543. doi: 10.1038/s41433-018-0106-3. Epub 2018 May 16. No abstract available.

  54. Khan KN, Kasilian M, Mahroo OAR, ,…, Fujinami K, et al. Early Patterns of Macular Degeneration in ABCA4-Associated Retinopathy. Ophthalmology. 2018 May;125(5):735-746. doi: 10.1016/j.ophtha.2017.11.020. Epub 2018 Jan 6.

  55. Kominami A, Ueno S, Kominami T, ,…, Fujinami K, et al. Case of cone dystrophy with normal fundus appearance associated with biallelic POC1B variants. Ophthalmic Genet. 2018 Apr;39(2):255-262. doi: 10.1080/13816810.2017.1408846. Epub 2017 Dec 8.

  56. Fiorentino A, Fujinami K, Arno G,  et al. Missense variants in the X-linked gene PRPS1 cause retinal degeneration in females. Hum Mutat. 2018 Jan;39(1):80-91. doi: 10.1002/humu.23349. Epub 2017 Oct 17.

  57. Kong X, West SK, Strauss RW,…, Fujinami K, et al. Progression of Visual Acuity and Fundus Autofluorescence in Recent-Onset Stargardt Disease: ProgStar Study Report #4. Ophthalmol Retina. 2017 Nov - Dec;1(6):514-523. doi: 10.1016/j.oret.2017.02.008. Epub 2017 Apr 28.

  58. Schönbach EM, Ibrahim MA, Strauss RW,…, Fujinami K, et al. Fixation Location and Stability Using the MP-1 Microperimeter in Stargardt Disease: ProgStar Report No. 3. Ophthalmol Retina. 2017 Jan - Feb;1(1):68-76. doi: 10.1016/j.oret.2016.08.009. Epub 2016 Oct 31.

  59. Kato Y, Hanazono G, Fujinami K, et al. Parafoveal Photoreceptor Abnormalities in Asymptomatic Patients With RP1L1 Mutations in Families With Occult Macular Dystrophy. Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6020-6029. doi: 10.1167/iovs.17-21969.

  60. Sasaki M, Kato Y, Fujinami K, et al. Advanced quantitative analysis of the sub-retinal pigment epithelial space in recurrent neovascular age-related macular degeneration. PLoS One. 2017 Nov 2;12(11):e0186955. doi: 10.1371/journal.pone.0186955. eCollection 2017.

  61. Strauss RW, Muñoz B, Ho A,…, Fujinami K, et al. Progression of Stargardt Disease as Determined by Fundus Autofluorescence in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 9). JAMA Ophthalmol. 2017 Nov 1;135(11):1232-1241. doi: 10.1001/jamaophthalmol.2017.4152.

  62. Kong X, Strauss RW, Cideciyan AV,…, Fujinami K, et al. Visual Acuity Change over 12 Months in the Prospective Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: ProgStar Report Number 6. Ophthalmology. 2017 Nov;124(11):1640-1651. doi: 10.1016/j.ophtha.2017.04.026. Epub 2017 May 23.

  63. Strauss RW, Muñoz B, Ho A,…, Fujinami K, et al. Incidence of Atrophic Lesions in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 5. JAMA Ophthalmol. 2017 Jul 1;135(7):687-695. doi: 10.1001/jamaophthalmol.2017.1121.

  64. Schönbach EM, Wolfson Y, Strauss RW,…, Fujinami K, et al. Macular Sensitivity Measured With Microperimetry in Stargardt Disease in the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Study: Report No. 7. JAMA Ophthalmol. 2017 Jul 1;135(7):696-703. doi: 10.1001/jamaophthalmol.2017.1162.

  65. Tanna P, Strauss RW, Fujinami K, et al. Stargardt disease: clinical features, molecular genetics, animal models and therapeutic options. Br J Ophthalmol. 2017 Jan;101(1):25-30. doi: 10.1136/bjophthalmol-2016-308823. Epub 2016 Aug 4. Review.

  66. Fakin A, Robson AG, Chiang JP,…, Fujinami K, et al. The Effect on Retinal Structure and Function of 15 Specific ABCA4 Mutations: A Detailed Examination of 82 Hemizygous Patients. Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):5963-5973. doi: 10.1167/iovs.16-20446.

  67. Fujinami K, Kameya S, Kikuchi S et al. Novel RP1L1 Variants and Genotype-Photoreceptor Microstructural Phenotype Associations in Cohort of Japanese Patients With Occult Macular Dystrophy. Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4837-46. doi: 10.1167/iovs.16-19670.

  68. Fakin A, Robson AG, Fujinami K, et al. Phenotype and Progression of Retinal Degeneration Associated With Nullizigosity of ABCA4. Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4668-78. doi: 10.1167/iovs.16-19829.

  69. Akiyama K, Fujinami K, Watanabe K, et al. Internal Limiting Membrane Peeling to Prevent Post-vitrectomy Epiretinal Membrane Development in Retinal Detachment. Am J Ophthalmol. 2016 Nov;171:1-10. doi: 10.1016/j.ajo.2016.08.015. Epub 2016 Aug 18.

  70. Nakamura N, Fujinami K, Mizuno Y, et al. Evaluation of cone function by a handheld non-mydriatic flicker electroretinogram device. Clin Ophthalmol. 2016 Jun 30;10:1175-85. doi: 10.2147/OPTH.S104721. eCollection 2016.

  71. Kong X, Strauss RW, Michaelides M,…, Fujinami K, et al. Visual Acuity Loss and Associated Risk Factors in the Retrospective Progression of Stargardt Disease Study (ProgStar Report No. 2). Ophthalmology. 2016 Sep;123(9):1887-97. doi: 10.1016/j.ophtha.2016.05.027. Epub 2016 Jul 2.

  72. Hirakata T*, Fujinami K*, Watanabe K et al. One-year outcome of intravitreal aflibercept injection for age-related macular degeneration resistant to ranibizumab: rapid morphologic recovery and subsequent visual improvement. Clin Ophthalmol. 2016 May 26;10:969-77. doi: 10.2147/OPTH.S101596. eCollection 2016.

  73. Kamoshita M, Fujinami K, Toda E, et al. Neuroprotective effect of activated 5'-adenosine monophosphate-activated protein kinase on cone system function during retinal inflammation. BMC Neurosci. 2016 Jun 10;17(1):32. doi: 10.1186/s12868-016-0268-5.

  74. Nakanishi A, Ueno S, Hayashi T,…, Fujinami K, et al. Clinical and Genetic Findings of Autosomal Recessive Bestrophinopathy in Japanese Cohort. Am J Ophthalmol. 2016 Aug;168:86-94. doi: 10.1016/j.ajo.2016.04.023. Epub 2016 May 7.

  75. Strauss RW, Ho A, Muñoz B,…, Fujinami K, et al. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1. Ophthalmology. 2016 Apr;123(4):817-28. doi: 10.1016/j.ophtha.2015.12.009. Epub 2016 Jan 16.

  76. Mizuno M*, Fujinami K*, Watanabe K et al. Macular Hole Associated with Vogt-Koyanagi-Harada Disease at the Acute Uveitic Stage. Case Rep Ophthalmol. 2015 Sep 15;6(3):328-32. doi: 10.1159/000440679. eCollection 2015 Sep-Dec.

  77. Kato Y, Tsunoda K, Fujinami K, et al. Association of Retinal Artery and Other Inner Retinal Structures With Distribution of Tapetal-like Reflex in Oguchi's Disease. Invest Ophthalmol Vis Sci. 2015 Apr;56(4):2162-72. doi: 10.1167/iovs.14-16198.

  78. Fujinami K, Zernant J, Chana RK et al. Clinical and molecular characteristics of childhood-onset Stargardt disease. Ophthalmology. 2015 Feb;122(2):326-34. doi: 10.1016/j.ophtha.2014.08.012. Epub 2014 Oct 12.

  79. Nishikawa Y*, Fujinami K*, Watanabe K et al. Clinical course of focal choroidal excavation in Vogt-Koyanagi-Harada disease. Clin Ophthalmol. 2014 Dec 4;8:2461-5. doi: 10.2147/OPTH.S75558. eCollection 2014.

  80. Singh R, Fujinami K, Moore AT, et al. Branch retinal artery occlusion secondary to prepapillary arterial loop. Retin Cases Brief Rep. 2014 Spring;8(2):124-6. doi: 10.1097/ICB.0000000000000020.

  81. Tanaka H*, Fujinami K*, Watanabe K et al. Haptic breakage after transscleral fixation of a single-piece acrylic intraocular lens. Case Rep Ophthalmol. 2014 Jul 12;5(2):212-6. doi: 10.1159/000365350. eCollection 2014 May.

  82. Yamazaki R, Tsunoda K, Fujinami K,  et al. Fundus autofluorescence imaging in a patient with the juvenile form of galactosialidosis. Ophthalmic Surg Lasers Imaging Retina. 2014 May-Jun;45(3):259-61. doi: 10.3928/23258160-20140425-01. Epub 2014 Apr 29.

  83. Singh R, Fujinami K†, Chen LL,  et al. Longitudinal follow-up of siblings with a discordant Stargardt disease phenotype. Acta Ophthalmol. 2014 Jun;92(4):e331-2. doi: 10.1111/aos.12280. Epub 2014 Jan 16. No abstract available.

  84. Fujinami K, Singh R, Carroll J et al. Fine central macular dots associated with childhood-onset Stargardt Disease. Acta Ophthalmol. 2014 Mar;92(2):e157-9. doi: 10.1111/aos.12259. Epub 2013 Sep 11. No abstract available.

  85. Fujinami K, Lois N, Mukherjee R et al. A longitudinal study of Stargardt disease: quantitative assessment of fundus autofluorescence, progression, and genotype correlations. Invest Ophthalmol Vis Sci. 2013 Dec 17;54(13):8181-90. doi: 10.1167/iovs.13-12104.

  86. Fujinami K, Zernant J, Chana RK et al. ABCA4 gene screening by next-generation sequencing in a British cohort. Invest Ophthalmol Vis Sci. 2013 Oct 11;54(10):6662-74. doi: 10.1167/iovs.13-12570.

  87. Fujinami K, Sergouniotis PI, Davidson AE et al. Clinical and molecular analysis of Stargardt disease with preserved foveal structure and function. Am J Ophthalmol. 2013 Sep;156(3):487-501.e1. doi: 10.1016/j.ajo.2013.05.003.

  88. Fujinami K, Tsunoda K, Nakamura N et al. Molecular characteristics of four Japanese cases with KCNV2 retinopathy: report of novel disease-causing variants. Mol Vis. 2013 Jul 20;19:1580-90. Print 2013.

  89. Fujinami K, Sergouniotis PI, Davidson AE et al. The clinical effect of homozygous ABCA4 alleles in 18 patients. Ophthalmology. 2013 Nov;120(11):2324-31. doi: 10.1016/j.ophtha.2013.04.016. Epub 2013 Jun 12.

  90. Fujinami K, Lois N, Davidson AE et al. A longitudinal study of stargardt disease: clinical and electrophysiologic assessment, progression, and genotype correlations. Am J Ophthalmol. 2013 Jun;155(6):1075-1088.e13. doi: 10.1016/j.ajo.2013.01.018. Epub 2013 Mar 15.

  91. Tsunoda K, Usui T, Hatase T, ,…, Fujinami K, et al. Clinical characteristics of occult macular dystrophy in family with mutation of RP1l1 gene. Retina. 2012 Jun;32(6):1135-47. doi: 10.1097/IAE.0b013e318232c32e.

  92. Fujinami K, Tsunoda K, Nakamura M et al. Oguchi disease with unusual findings associated with a heterozygous mutation in the SAG gene. Arch Ophthalmol. 2011 Oct;129(10):1375-6. doi: 10.1001/archophthalmol.2011.300. No abstract available.

  93. Chai Y, Yamazaki H, Fujinami K,  et al. Case of acute zonal occult outer retinopathy with abnormal pattern visual evoked potentials. Clin Ophthalmol. 2011;5:1235-41. doi: 10.2147/OPTH.S23194. Epub 2011 Sep 6.

  94. Tsunoda K, Fujinami K, Miyake Y.,  et al. Selective abnormality of cone outer segment tip line in acute zonal occult outer retinopathy as observed by spectral-domain optical coherence tomography. Arch Ophthalmol. 2011 Aug;129(8):1099-101. doi: 10.1001/archophthalmol.2011.217. No abstract available.

  95. Fujinami K, Tsunoda K, Hanazono G et al. Fundus autofluorescence in autosomal dominant occult macular dystrophy. Arch Ophthalmol. 2011 May;129(5):597-602. doi: 10.1001/archophthalmol.2011.96.

  96. Fujinami K, Akahori M, Fukui M et al. Stargardt disease with preserved central vision: identification of a putative novel mutation in ATP-binding cassette transporter gene. Acta Ophthalmol. 2011 May;89(3):e297-8. doi: 10.1111/j.1755-3768.2009.01848.x. No abstract available.

  97. Fujinami K, Yokoi T, Hiraoka M et al. Choroidal neovascularization in a child following laser pointer-induced macular injury. Jpn J Ophthalmol. 2010 Nov;54(6):631-3. doi: 10.1007/s10384-010-0876-z. Epub 2010 Dec 30. No abstract available.

  98. Terauchi N, Fujinami K, Shinoda K, et al. Transient macular dysfunction determined by focal macular electroretinogram. Br J Ophthalmol. 2007 Dec;91(12):1709-10. No abstract available.

bottom of page